Researchers at Texas A&M University have developed a nasal spray that shows potential in reversing brain aging, improving memory, and reducing inflammation, with implications for conditions such as dementia and Alzheimer’s disease.
Researchers at Texas A&M University have announced a groundbreaking study indicating that a simple nasal spray may reverse the effects of brain aging, potentially offering new therapeutic avenues for conditions linked to cognitive decline, such as dementia and Alzheimer’s disease. The study, led by Dr. Ashok Shetty, a university distinguished professor and associate director of the Institute for Regenerative Medicine, was published in the Journal of Extracellular Vesicles.
In their research, scientists demonstrated that the nasal spray treatment could restore memory functions, reduce chronic inflammation, and enhance brain cell performance after administering just two doses. This development comes in light of longstanding scientific understanding that aging brains often endure persistent low-level inflammation, a phenomenon termed “neuroinflammaging.” This chronic state of inflammation is known to disrupt cognitive functions, including memory and adaptability, and is regarded as a significant contributor to neurodegenerative diseases.
Mechanism of Action
The novel therapy relies on extracellular vesicles (EVs), which are microscopic biological particles that facilitate communication between cells by transporting genetic material. The researchers engineered these EVs to carry microRNAs, which are molecules that help regulate a variety of biological processes within the brain. According to Dr. Madhu Leelavathi Narayana, one of the senior research scientists involved in the study, “MicroRNAs act like master regulators. They help modulate and regulate many gene and signaling pathways in the brain.”
By using a nasal spray method, the treatment bypasses the brain’s protective barrier, enabling direct delivery of the therapeutic agents to brain tissue. Dr. Maheedhar Kodali highlighted, “The mode of delivery is one of the most exciting aspects of our approach. Intranasal delivery allows us to reach, and treat, the brain directly without invasive procedures.” Once in the brain, the treatment specifically targets immune cells responsible for chronic inflammation, effectively suppressing inflammatory systems such as the NLRP3 inflammasome and cGAS-STING signaling pathways, both of which are closely linked to age-related brain inflammation.
Restoration of Cellular Function
Beyond merely reducing inflammation, the therapy appears to restore mitochondrial function within brain cells. Mitochondria are vital components of cells responsible for energy production, and their impairment due to aging and inflammation can leave brain cells ineffective and vulnerable. The researchers found that by enhancing mitochondrial activity, the treatment helps neurons recover their capacity to process and store information. As Narayana noted, “We are giving neurons their spark back by reducing oxidative stress and reactivating the brain’s mitochondria.” Behavioral assessments indicated that treated subjects performed significantly better in memory and recognition tasks compared to untreated controls, displaying improved abilities to identify familiar objects and recognize changes in their environment.
Broader Implications for Dementia Treatment
The findings from this study could have far-reaching implications, particularly as the incidence of dementia is projected to rise. In the United States alone, annual dementia cases are expected to increase from approximately 514,000 in 2020 to nearly 1 million by 2060. Dr. Shetty emphasized the urgent need for innovative interventions, stating, “The trend signals a pressing need for policies and innovative interventions that can minimize both the risk and severity of neurodegenerative disorders like dementia.” Notably, the study also revealed consistent treatment responses across both sexes, which is often uncommon in biomedical research. Dr. Shetty remarked, “It’s universal. Treatment outcomes were consistent and similar across both sexes.”
The researchers envision that this therapy could also assist stroke patients in regaining cognitive functions or mitigate cognitive decline associated with aging. Dr. Shetty stated, “Our approach redefines what it means to grow old. We’re aiming for successful brain aging: keeping people engaged, alert and connected. Not just living longer, but living smarter and healthier.”
Future Directions in Brain Aging Research
This research received support from the National Institute on Aging (NIA), and the team has filed a U.S. patent related to the therapy. Dr. Shetty asserted that their focus extends beyond understanding the biology of aging brains to developing actionable treatments that could benefit patients. He noted, “We aren’t just trying to understand the biological mechanisms; we are translating and developing our findings into real-world therapies that could make a difference.” While further research is necessary before human trials can commence, the study presents a compelling possibility: the notion that brain aging may not be an inevitable aspect of growing older.
Dr. Shetty concluded, “Our partnership with the NIA is very important. This kind of work requires resources and the right people to tackle problems and develop solutions that could change lives.”
No Comment! Be the first one.